KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) FCF Margin (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of FCF Margin data on record, last reported at 96.99% in Q4 2025.

  • For Q4 2025, FCF Margin rose 5808.0% year-over-year to 96.99%; the TTM value through Dec 2025 reached 57.81%, up 2350.0%, while the annual FY2025 figure was 30.39%, 391.0% down from the prior year.
  • FCF Margin reached 96.99% in Q4 2025 per JAZZ's latest filing, up from 7.26% in the prior quarter.
  • Across five years, FCF Margin topped out at 96.99% in Q4 2025 and bottomed at 4.59% in Q2 2021.
  • Average FCF Margin over 5 years is 32.73%, with a median of 31.44% recorded in 2021.
  • Peak YoY movement for FCF Margin: crashed -2738bps in 2021, then soared 5808bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 18.71% in 2021, then soared by 83bps to 34.21% in 2022, then tumbled by -55bps to 15.54% in 2023, then soared by 150bps to 38.91% in 2024, then surged by 149bps to 96.99% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 96.99% in Q4 2025, 7.26% in Q2 2025, and 38.91% in Q4 2024.